Best Doctors for Bone Marrow Transplant in Delhi NCR, India

Dr. Vinod Raina is a distinguished figure in the field of Medical Oncology in India, with over 40 years of exemplary experience. He is currently associated with Fortis Memorial Research Institute in Gurugram, where he functions as the Chairman and Head of Medical Oncology and Hematology. His primary expertise lies in chemotherapy treatment and he was the first to perform high-dose chemotherapy in India. He also performed the first peripheral blood BMT in India — milestones that placed him at the frontier of oncology practice in the country during a period when these techniques were only available in the most advanced centres globally. Dr. Raina possesses specialised expertise in treating a wide spectrum of cancers including breast cancer, lung cancer, gastrointestinal cancer, urological cancer, gynaecological cancer, lymphoma, and myeloma. His contributions extend to performing approximately 400 BMTs, significantly enhancing treatment options for various cancers in India. Before joining Fortis, Dr. Raina was part of other renowned cancer hospitals such as the All India Institute of Medical Sciences (AIIMS), where during the last decade he performed the largest number of cancer-related transplants in India. He served as a Professor and Head of Medical Oncology at AIIMS, New Delhi, where he garnered immense respect for his knowledge and leadership. Throughout his career, Dr. Raina has worked across hospitals and medical institutes both in India and abroad. During his stint at AIIMS, he was the Principal Investigator of over 50 projects where he showcased his commitment to advancing oncology through rigorous scientific inquiry. He also co-founded the INDOX network, furthering collaborative research efforts in oncology. Moreover, he has been conducting the DM course for Medical Oncology for the last 15 years and has trained more than 70 residents and DM students at AIIMS, many of whom now occupy prominent positions in the field globally. He holds more than 200 publications in national and international medical journals worldwide.

Dr. Nitin Sood is Vice Chairman of the Hematology department at Medanta — The Medicity in Gurgaon, one of India's leading tertiary-care institutions. With over 28 years of clinical experience, he is a highly trained hematologist and medical oncologist holding advanced qualifications including FRCPath, MRCPath, and MRCP (UK). His credentials reflect a rigorous educational pathway: MBBS from Mysore University (1998), MD in General Medicine and DNB in Internal Medicine from Delhi University (both 2002), and specialized training in clinical hematology through a CCT qualification completed in the United Kingdom. Dr. Sood's clinical expertise spans the full spectrum of hematologic malignancies and benign blood disorders. He has extensive experience managing acute and chronic leukemias, lymphomas, multiple myeloma, and myelodysplastic syndromes. He is particularly skilled in bone marrow and stem cell transplantation, including haploidentical transplant approaches, as well as the management of bleeding and clotting disorders, hemophilia, sickle cell disease, thalassemias, and aplastic anemia. His practice reflects both diagnostic acumen and therapeutic sophistication, supported by high patient volumes and contemporary clinical protocols. Dr. Sood regularly treats patients from across the Gulf region, Africa, and the broader international community who seek specialized hematology and oncology care. His fluency in English and Hindi, combined with Medanta's robust international patient services, ensures seamless communication and coordinated care for overseas patients. He understands the complexities of traveling for treatment and tailors clinical schedules and follow-up arrangements accordingly. Medanta — The Medicity is accredited by NABH and JCI, with state-of-the-art hematology laboratories, dedicated stem cell transplant units, and on-site oncology services. The hospital's location in Gurgaon provides excellent connectivity via Delhi, and the institution maintains dedicated international patient coordinators who assist with visa facilitation, accommodation, and treatment logistics. For international patients seeking expert hematology and oncology care in India, Dr. Sood's profile at Medanta represents a compelling combination of clinical depth, institutional infrastructure, and patient-centered support.

Dr. Dharma Choudhary is Chairman of Haemato-Oncology and Bone Marrow Transplant at BLK-Max Super Speciality Hospital in New Delhi, bringing over 23 years of clinical expertise in blood disorders and transplant medicine. He holds a DM in Clinical Haematology from AIIMS New Delhi and is a life member of the Indian Society of Haematology & Transfusion Medicine, as well as a member of the American Society of Blood and Marrow Transplant. His academic foundation spans fellowships at leading centres including Christian Medical College Vellore, Sanjay Gandhi Post Graduate Institute Lucknow, and the BC Cancer Agency in Vancouver, establishing him as a globally trained specialist. Dr. Choudhary has performed over 2,000 bone marrow transplants, making him one of India's most accomplished transplant surgeons. His clinical repertoire encompasses allogeneic, autologous, and haploidentical transplants, alongside matched sibling donor transplantation. He treats acute leukaemias, myelodysplastic syndromes, bone marrow failure syndromes, and solid tumour chemotherapy with equal proficiency. His systematic approach to patient evaluation and post-transplant care has built a reputation for achieving strong clinical outcomes in complex haematological malignancies. International patients from the Gulf states, Africa, and South Asia regularly travel to New Delhi for Dr. Choudhary's consultation and transplant programmes. He manages the full treatment journey—from initial diagnosis and donor evaluation through long-term follow-up—and works closely with Gaf Healthcare to streamline referrals, arrange local accommodation, and provide interpreter support for non-Hindi-speaking patients. His compassionate communication style and willingness to discuss alternative treatment options make him a trusted advisor for families facing challenging blood disorders. BLK-Max Super Speciality Hospital is one of India's premier multi-specialty centres with NABH accreditation, dedicated bone marrow transplant ICU facilities, and a robust international patient services desk. The hospital's proximity to Delhi's international airport and its established infrastructure for managing complex transplant cases make it a natural hub for medical tourism in haemato-oncology. Dr. Choudhary's leadership position ensures that international patients receive coordinated care with access to allied specialists, diagnostic imaging, and transfusion medicine under one roof, reducing logistical fragmentation and improving treatment continuity.

Dr. Vishnu Hari is an Associate Director and Head of Unit I in Medical Oncology, Haematology, and Bone Marrow Transplantation at Sarvodaya Hospital in Faridabad. With more than 16 years of clinical experience, he brings deep expertise in diagnosing and treating a broad spectrum of solid and haematological malignancies. His comprehensive training at the Regional Cancer Centre, Trivandrum, combined with his qualifications in internal medicine and general medicine from Government Medical College, Calicut, has established a strong academic and clinical foundation. Dr. Hari's clinical proficiency encompasses the management of leukaemia, lymphoma, myeloma, breast cancer, sarcoma, gastrointestinal cancers, and genitourinary cancers. He is highly skilled in advanced treatment modalities including stem cell transplantation, cancer immunotherapy, targeted therapy, CAR-T cell therapy, and precision oncology. His expertise in oncology critical care ensures that patients with complex presentations receive comprehensive, multidisciplinary support throughout their treatment journey. International patients from the Gulf region, Africa, and South Asia seek Dr. Hari's care for complex oncology cases. He maintains a patient-centric approach, taking time to explain treatment options in clear language and ensuring families understand the clinical pathway. His experience treating international patients has equipped him with cultural sensitivity and a commitment to coordinating care seamlessly across borders. Sarvodaya Hospital, located in Sector 8 of Faridabad, is an established tertiary cancer centre with state-of-the-art oncology facilities, dedicated haematology-BMT units, and comprehensive critical care infrastructure. The hospital prioritizes international patient support with dedicated consultation coordinators, translation services, and streamlined admission processes. Patients from overseas benefit from the hospital's integration of global treatment protocols with local expertise, making complex cancer care both accessible and affordable. International patients considering treatment in India should know that Dr. Hari's unit maintains standards aligned with ASCO and ESMO guidelines, ensuring evidence-based care regardless of origin. Gaf Healthcare can facilitate initial video consultations, arrange document reviews, and coordinate logistics for international patients seeking second opinions or comprehensive oncology management.

Dr. Jasmine Porwal is a Consultant in Medical Oncology and Cancer Care at Medanta — The Medicity in Gurgaon, bringing over 12 years of clinical expertise to comprehensive cancer management. She holds a DM in Medical Oncology from the All India Institute of Medical Sciences (AIIMS) in New Delhi, along with an MD in Internal Medicine from PGIMER – Dr. RML Hospital, New Delhi. Her rigorous training in evidence-based oncology and prior experience as a Senior Research Fellow at AIIMS Delhi (Indian Institute of Rotary Cancer Hospital) have shaped her approach to precision cancer care. Dr. Porwal specializes in the management of solid tumours and haematological malignancies, with particular expertise in chemotherapy regimens—both adjuvant and neoadjuvant—as well as modern immunotherapy and molecular targeted therapy. She is skilled in immune checkpoint inhibitor therapy, manages oncological emergencies with clinical acuity, and provides compassionate palliative care tailored to each patient's goals. Her experience also extends to bone marrow transplantation and complex treatment sequencing under both optimal and resource-constrained settings. She has published her clinical research in leading international journals including the Journal of Clinical Oncology, Annals of Oncology, and Blood, reflecting her commitment to advancing cancer treatment outcomes through rigorous clinical investigation. International patients from the Gulf region, Africa, and SAARC countries form a significant part of her practice. Dr. Porwal is fluent in English and Hindi, ensuring clear communication with patients from diverse backgrounds. She takes a patient-centred approach, discussing treatment options transparently and involving families in decision-making. Her clinic at Medanta welcomes patients seeking second opinions, comprehensive staging, treatment planning, and ongoing supportive care for both newly diagnosed and recurrent cancers. Medanta — The Medicity is a NABH and JCI-accredited tertiary care institution in Gurgaon, known for its comprehensive oncology centre with advanced diagnostic imaging, chemotherapy suites, and integrated palliative services. The hospital's international patient desk, dedicated translators, and streamlined admission processes make it a preferred destination for cancer patients across South Asia, the Middle East, and Africa seeking world-standard care at reasonable costs. Dr. Porwal's tenure at premier institutions including Safdarjung Hospital and the National Cancer Institute, Jhajjar, has further refined her expertise in managing complex oncological scenarios and leading clinical trials. Patients choosing Dr. Porwal benefit from her evidence-based, compassionate approach and access to Medanta's state-of-the-art facilities. International patients are advised to connect via Gaf Healthcare to arrange initial video consultations, document review, and streamlined travel and treatment planning for their cancer care journey.

Dr. Suhail Qureshi is an Additional Director and Unit Head of Medical Oncology at Fortis Hospital, Shalimar Bagh, New Delhi, bringing 11 years of dedicated clinical experience in the diagnosis and treatment of diverse malignancies. He is a highly trained medical oncologist with advanced qualifications from some of India's most respected institutions, including a fellowship in Medical Oncology, Hematology and Bone Marrow Transplantation from Medanta, The Medicity, Gurugram. Dr. Qureshi's clinical expertise spans the full spectrum of cancer care, from chemotherapy for solid tumors and hematologic malignancies to advanced immunotherapy and molecular targeted therapies. He has specialized training in adjuvant and neoadjuvant chemotherapy, palliative oncology, hormone therapies for breast and prostate cancers, and autologous bone marrow transplantation. His comprehensive approach ensures that each patient receives individualized treatment tailored to their cancer type, stage, and overall health status. With a patient-centered philosophy, Dr. Qureshi is experienced in managing international patients seeking oncology care from the Gulf region, Africa, and the SAARC countries. He combines evidence-based treatment protocols with compassionate support, making him a trusted choice for families navigating complex cancer diagnoses. His active engagement with international oncology conferences and contributions to peer-reviewed publications demonstrate his commitment to staying current with evolving treatment paradigms. Fortis Hospital, Shalimar Bagh is a leading tertiary care center in New Delhi, accredited with advanced oncology infrastructure, multimodal imaging, and supportive care facilities. The hospital's international patient services team facilitates seamless coordination for overseas patients, including visa assistance, accommodation guidance, and multilingual support. For international patients choosing treatment in New Delhi, Dr. Qureshi's expertise combined with Fortis's world-class facilities offers comprehensive, accessible cancer care.

Dr. Divya Doval is a Senior Consultant in Haemato-Oncology and Bone Marrow Transplant at BLK-Max Super Speciality Hospital, New Delhi. With over 11 years of clinical experience and an exceptional track record of more than 1,500 successful transplants, she has established herself as a leading bone marrow transplant specialist in India. Her academic credentials include MBBS, MRCPCH from the Royal College of Paediatrics and Child Health (UK), and specialized fellowships in CAR-T Cell Therapy from Royal Marsden Hospital in London and in Haemato-Oncology and Bone Marrow Transplant from BLK Super Speciality Hospital. Dr. Doval's clinical expertise spans the full spectrum of bone marrow transplant procedures, including allogeneic, autologous, and haploidentical transplants with matched sibling and unrelated donors. She is particularly skilled in managing acute leukemia, myelodysplastic syndromes, bone marrow failure syndromes, and pediatric conditions such as thalassemia and aplastic anemia. Her proficiency in CAR-T cell therapy represents one of the most advanced immunotherapeutic approaches in hematologic malignancies. Her approach to case selection, donor matching, and post-transplant management reflects both evidence-based protocols and personalized clinical judgment honed over thousands of procedures. International patients from the Gulf region, Africa, and SAARC countries seek Dr. Doval's expertise for complex hematologic and transplant management. She is fluent in English and Hindi, and the hospital provides dedicated international patient support to ensure seamless communication and care coordination. Many patients return for follow-up management, reflecting the trust built through transparency, clinical excellence, and compassionate care. The Centre for Bone Marrow Transplant at BLK-Max has become a preferred destination for families seeking second opinions and definitive transplant intervention. BLK-Max Super Speciality Hospital in New Delhi is a NABH-accredited, multi-specialty tertiary care centre with world-class infrastructure for transplant care. The hospital features dedicated transplant wards with HEPA-filtered isolation units, advanced laboratory facilities for HLA typing and chimerism monitoring, and a robust supportive care team including specialized nutritionists, psychologists, and infectious disease specialists. The Centre for Bone Marrow Transplant operates with modern protocols aligned with international guidelines, and the hospital maintains comprehensive records for long-term follow-up and outcome tracking. For international patients, the hospital's international desk arranges logistics, accommodation liaisons, and coordinated care schedules. When considering bone marrow transplant abroad, international patients should know that Dr. Doval's centre offers transplantation at a cost-effective level compared to Western centres, without compromise on sterility standards, donor selection rigor, or post-transplant follow-up intensity. The hospital's experience with patients from multiple countries has refined protocols for managing time-zone coordination, remote consultations, and ensuring continuity of care upon return home.

Dr. Akash Khandelwal is a distinguished consultant hematologist and hemato-oncologist with over 10 years of clinical expertise in complex blood disorders and hematologic malignancies. As Consultant and Unit Head of the Department of Hematology, Hemato-Oncology, and Bone Marrow Transplant at Fortis Hospital Shalimar Bagh in New Delhi, he brings academic rigor from his DM training at the prestigious All India Institute of Medical Sciences (AIIMS), one of India's foremost medical institutions, combined with profound practical experience in advanced transplant medicine. Dr. Khandelwal has personally supervised and conducted over 100 bone marrow transplants, including autologous stem cell transplants, matched sibling donor, matched unrelated donor, and haploidentical donor procedures. His clinical depth spans the full spectrum of hematologic conditions: acute and chronic leukemias, lymphomas, multiple myeloma, myelodysplastic syndromes, thalassemia, sickle cell disease, aplastic anemia, and myeloproliferative neoplasms. He is also experienced in cutting-edge immunotherapy, including CAR-T cell therapy, positioning him at the forefront of modern blood cancer treatment. Dr. Khandelwal treats a substantial number of international patients from the Gulf region, Africa, and South Asia who seek specialized bone marrow transplant and hemato-oncology care in India. His hospital affiliation with Fortis Shalimar Bagh—a major multispecialty center in New Delhi—ensures comprehensive support for complex cases, including dedicated transplant units, advanced diagnostic facilities, and seamless coordination for overseas patients. He also maintains active associations with other leading institutions including BLK-MAX Hospital and Action Balaji Cancer Hospital in New Delhi, further expanding his clinical network. Fortis Hospital Shalimar Bagh is accredited under NABH standards and maintains international protocols for patient care. The hospital offers 24/7 ICU support, state-of-the-art imaging, and dedicated hemato-oncology wards essential for transplant recovery. For international patients, the hospital has a well-established medical tourism desk and provides language support in English and regional languages. Patients traveling to New Delhi for bone marrow transplant or blood cancer treatment benefit from the city's well-connected international airport, accessible accommodation, and robust follow-up care infrastructure. When seeking bone marrow transplant or hemato-oncology consultation in India, Dr. Khandelwal's combination of AIIMS training, high transplant volume, and systematic approach to international patient care makes Fortis Shalimar Bagh a dependable destination. International patients should know that bone marrow transplant timelines typically span 3–4 weeks for donor evaluation and transplant, with post-transplant stay extending to 4–8 weeks depending on complications. Most international patients coordinate their visits through Gaf Healthcare for seamless booking and in-country logistics.

Dr. Devanshee Aakash Shah is an accomplished Medical Oncologist with over 8 years of clinical experience in managing complex cancer cases. She holds an MBBS from BJMC, MD in Internal Medicine, and a DM in Medical Oncology from NHL MMC, complemented by advanced certifications including Harvard Medical School eDiploma in Advanced Management of Oncological Diseases and ESMO certification from the European Society of Medical Oncology. Currently serving as Associate Consultant in Medical Oncology at Paras Hospitals in Gurugram, Dr. Shah brings a comprehensive, evidence-based approach to cancer diagnosis and treatment. Dr. Shah's clinical expertise spans a broad spectrum of oncological conditions, including lung cancer, head and neck cancers, hematological malignancies, breast and gynecological cancers, gastrointestinal cancers, and genitourinary cancers. She specializes in chemotherapy for solid tumors, adjuvant and neoadjuvant chemotherapy, immunotherapy for advanced cancer, immune checkpoint inhibitor therapy, molecular targeted therapy, and biomarker-based treatment protocols. Her proficiency in autologous bone marrow transplantation and multiple myeloma management reflects her depth in complex hematologic malignancies. With ECMO certification and extensive clinical volumes, she combines technical precision with personalized cancer care strategies. Dr. Shah is highly experienced in treating international patients seeking specialized oncology care in India. She welcomes patients from the Gulf region, Africa, and Southeast Asia, offering multilingual support in English and Hindi. Her patient-centered approach emphasizes quality of life, novel treatment protocols, and collaborative care planning. She previously served as Assistant Professor at Tata Memorial Hospital, Mumbai—one of India's foremost cancer research and treatment centers—an experience that strengthened her commitment to clinical excellence and evidence-based practice. Paras Hospitals in Gurugram is a nationally accredited, multispecialty tertiary care center known for its oncology department, advanced diagnostic imaging, and comprehensive cancer support services. The hospital attracts international patients due to its NABH accreditation, experienced oncology team, and cost-effective treatment protocols compared to Western centers. Dr. Shah's affiliation with Paras places her at a hub of cancer care innovation, where she integrates cutting-edge therapies with compassionate patient management. International patients choosing Dr. Shah benefit from world-class oncology expertise at a fraction of the cost available in Europe or North America, combined with personalized follow-up care and seamless coordination through Gaf Healthcare.

Dr. Mehak Trehan is an Associate Consultant in Hemato-Oncology and Bone Marrow Transplant at Fortis Memorial Research Institute, Gurgaon. A Clinical Hematologist and Hemato-Oncologist with over 6 years of professional experience, she brings a distinguished academic background marked by exceptional achievements across all stages of her medical training. Dr. Trehan completed her MBBS (Hons.) as Best Outgoing Student and earned a Gold Medal in her MD in Medicine for academic excellence. She further specialised with a DM in Clinical Hematology from the All India Institute of Medical Sciences (AIIMS), New Delhi — one of India's premier medical institutions — where she was again awarded a Gold Medal for outstanding performance. Dr. Trehan's clinical expertise spans the full spectrum of hematological malignancies and blood disorders. She specialises in treating acute and chronic leukemias, lymphomas, multiple myeloma, and myelodysplastic syndromes. Her particular clinical focus includes bone marrow transplantation, including haploidentical transplant procedures, chemotherapy for blood cancers, and cancer immunotherapy. She has developed strong technical and clinical competencies in managing complex blood disorders such as thalassemia and sickle cell disease, combining evidence-based medicine with compassionate patient care. Dr. Trehan is committed to serving international patients seeking expert hematologic care. She welcomes patients from the Gulf region, Africa, and the broader SAARC region, providing professional consultation and treatment planning in English and Hindi. Her practice at Fortis Memorial Research Institute positions her to manage both routine and highly complex cases, offering continuity of care and access to advanced diagnostic and therapeutic technologies. She maintains active membership in several prestigious national and international societies, including ASCO, SOHO, ASTCT, ISHBT, and the MHG Group, ensuring her practice remains aligned with global standards in hematology and oncology. Fortis Memorial Research Institute in Gurgaon is a leading multi-specialty tertiary care facility renowned for its haematology and oncology departments. The hospital is equipped with state-of-the-art diagnostic facilities, ICU support, and specialised wards for cancer and transplant patients. Its international patient services desk, NABH accreditation, and track record in managing complex blood cancers make it a preferred destination for patients seeking advanced hematologic care. International patients benefit from coordinated care pathways, dedicated translators, and organised logistics support, ensuring a seamless treatment experience in India.

Dr. Bhaarat is a Consultant Hemato-Oncologist at Medanta — The Medicity in Gurugram, specializing in the diagnosis and treatment of blood cancers and hematological disorders. He holds an MBBS degree, an MD in Medicine, and a DrNB in Clinical Hematology from the prestigious Rajiv Gandhi Cancer Institute & Research Centre, New Delhi (2018–2021), where he trained under nationally recognized hemato-oncologists. His expertise spans the full spectrum of hematological malignancies and benign blood disorders. With over 5 years of clinical experience, Dr. Bhaarat has personally participated in more than 100 bone marrow transplant procedures, including autologous, matched sibling donor (MSD) allogeneic, matched unrelated donor (MUD) allogeneic, and haploidentical haematopoietic stem cell transplants (HSCT). He is proficient in managing acute and chronic leukemia, lymphoma, multiple myeloma, and bone marrow failure syndromes. His procedural skills include bone marrow aspiration and biopsy, lumbar puncture, intrathecal chemotherapy, and comprehensive hematological diagnostics. He completed the Dana-Farber Cancer Institute's Acute Lymphoblastic Leukemia Preceptorship Program, further refining his approach to complex leukemia management. Dr. Bhaarat is known for his patient-centric approach and has built a strong reputation for treating international patients seeking world-standard care in India. He regularly welcomes patients from the Gulf Cooperation Council (GCC) nations, Africa, and South Asian countries, offering comprehensive consultation, treatment planning, and long-term follow-up. His bilingual fluency in English and Hindi ensures clear communication with diverse patient populations, making the medical journey seamless for those traveling to India for specialized hematology and transplant care. Medanta — The Medicity stands as one of India's premier multi-specialty healthcare institutions, featuring state-of-the-art ICU and transplant facilities, NABH accreditation, and an established international patient services team. Located in Gurugram, a major business and healthcare hub near Delhi, the hospital offers convenient access for international travelers and comprehensive support throughout the treatment journey. Patients choosing Dr. Bhaarat benefit from both his specialized expertise and Medanta's world-class infrastructure, making it an ideal destination for those seeking advanced hematology and bone marrow transplant services in South Asia.